Seeing Is Believing
Currently out of the existing stock ratings of Robert Hazlett, 63 are a BUY (90%), 6 are a HOLD (8.57%), 1 are a SELL (1.43%).
Analyst Robert Hazlett, carries an average stock price target met ratio of 26.39% that have a potential upside of 28.74% achieved within 137 days. Previously, Robert Hazlett worked at BTIG.
Robert Hazlett’s has documented 122 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AURA, Aura Biosciences at 18-Oct-2024.
Analyst best performing recommendations are on AXSM (AXSOME THERAPEUTICS).
The best stock recommendation documented was for AXSM (AXSOME THERAPEUTICS) at 12/17/2019. The price target of $97 was fulfilled within 3 days with a profit of $16.03 (19.8%) receiving and performance score of 65.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$132
$0.13 (0.10%)
$132
2 months 23 days ago
(02-Apr-2025)
28/30 (93.33%)
$0.13 (0.10%)
476
Buy
$132
$0.13 (0.10%)
$100
4 months 1 days ago
(24-Feb-2025)
10/11 (90.91%)
$3.46 (2.69%)
292
Hold
$100
4 months 4 days ago
(21-Feb-2025)
21/22 (95.45%)
$-27.19 (-21.38%)
170
Hold
$132
$0.13 (0.10%)
$113
4 months 25 days ago
(31-Jan-2025)
12/13 (92.31%)
$4.92 (3.87%)
738
Hold
$132
$0.13 (0.10%)
$108
5 months 3 days ago
(22-Jan-2025)
24/25 (96%)
$4.85 (3.81%)
233
What Year was the first public recommendation made by Robert Hazlett?